Skip to main content
SLS logo

SLS · SELLAS Life Sciences Group, Inc. · Fails to Deliver

Track SLS — free
$11.35 -0.79 (-6.51%) At close · Oct 22
Market Cap
$2.45B
Shares
201.95M
Volume · Oct 22 6.51M Avg daily vol (3M) 6.5M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-09-30 2,545 $11.51 $29,293
2026-09-29 1,024 $11.59 $11,868
2026-09-25 17,303 $11.98 $207,290
2026-09-24 40,679 $11.52 $468,622
2026-09-23 9,737 $12.02 $117,039
2026-09-22 34,249 $11.37 $389,411
2026-09-21 140,822 $11.49 $1,618,045
2026-09-18 108,639 $11.53 $1,252,608
2026-09-17 5,310 $11.66 $61,915
2026-09-16 6,990 $11.29 $78,917
2026-09-15 121,577 $11.73 $1,426,098
2026-09-14 990 $11.55 $11,435
2026-09-11 855 $13.49 $11,534
2026-09-10 11,559 $13.95 $161,248
2026-09-09 66,656 $13.96 $930,518
2026-09-08 95,897 $13.86 $1,329,132
2026-09-04 74,952 $13.70 $1,026,842
2026-09-03 159,411 $14.16 $2,257,260
2026-09-02 180,239 $13.22 $2,382,760
2026-09-01 403,160 $13.34 $5,378,154
2026-08-31 369,763 $13.21 $4,884,569
2026-08-28 100,888 $15.21 $1,534,506
2026-08-27 15,564 $13.73 $213,694
2026-08-26 13,554 $14.09 $190,976
2026-08-25 22,982 $14.33 $329,332
2026-08-24 45,832 $15.46 $708,563
2026-08-21 27,716 $13.40 $371,394
2026-08-19 28,707 $13.10 $376,062
2026-08-18 5,746 $13.00 $74,698
2026-08-17 9,848 $12.78 $125,857
2026-08-14 44,054 $12.36 $544,507
2026-08-13 1,175 $11.77 $13,830
2026-08-12 232,228 $11.05 $2,566,119
2026-08-10 72,889 $12.01 $875,397
2026-08-06 474,248 $11.86 $5,624,581
2026-08-05 61,768 $11.81 $729,480
2026-08-04 16,052 $11.22 $180,103
2026-08-03 8,976 $10.01 $89,850
2026-07-31 6,559 $10.29 $67,492
2026-07-30 3,666 $10.10 $37,027
2026-07-29 33,812 $10.09 $341,163
2026-07-28 93,890 $10.84 $1,017,768
2026-07-27 491,784 $11.32 $5,566,995
2026-07-24 121,438 $12.34 $1,498,545
2026-07-23 31,047 $12.08 $375,048
Showing 1–45 of 45 settlements
Key facts CIK 1390478 CUSIP 81642T209 13F (30d) 33 filings 33 filers Visit website Investor relations